A more objective approach to the evaluation of antimicrobial therapy in cystic fibrosis

Acta Univ Carol Med (Praha). 1990;36(1-4):44-5.

Abstract

Thirteen biochemical markers of infection and inflammation were measured during anti-Pseudomonas therapy in cystic fibrosis (CF) patients with respiratory exacerbation. The assessment of some of these markers is thought to be helpful in the evaluation of efficacy of antibiotic therapy in CF.

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents / therapeutic use*
  • Biomarkers
  • Child
  • Child, Preschool
  • Cystic Fibrosis / blood
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / drug therapy*
  • Female
  • Humans
  • Male
  • Pseudomonas Infections / blood
  • Pseudomonas Infections / complications
  • Pseudomonas Infections / drug therapy
  • Respiratory Tract Infections / blood
  • Respiratory Tract Infections / complications
  • Respiratory Tract Infections / drug therapy

Substances

  • Anti-Bacterial Agents
  • Biomarkers